Population impact of direct-acting antiviral treatment on new presentations of hepatitis C-related decompensated cirrhosis: a national record-linkage study

Sharon Hutchinson, Heather Valerio, Scott McDonald, Alan Yeung, Kevin Pollock, Shanley Smith, Stephen Barclay, John Dillon, Raymond Fox, Peter Bramley, Andrew Fraser, Nicholas Kennedy, Rory Gunson, Kate Templeton, Hamish Innes, Allan McLeod, Amanda Weir, Peter Hayes, David Goldberg
DOI

Population impact of direct-acting antiviral treatment on new presentations of hepatitis C-related decompensated cirrhosis: a national record-linkage study

Sharon Hutchinson, Heather Valerio, Scott McDonald, Alan Yeung, Kevin Pollock, Shanley Smith, Stephen Barclay, John Dillon, Raymond Fox, Peter Bramley, Andrew Fraser, Nicholas Kennedy, Rory Gunson, Kate Templeton, Hamish Innes, Allan McLeod, Amanda Weir, Peter Hayes, David Goldberg
DOI

Abstract

Population-based studies demonstrating the clinical impact of interferon-free direct-acting antiviral (DAA) therapies are lacking. We examined the impact of the introduction of DAAs on HCV-related decompensated cirrhosis (DC) through analysis of population-based data from Scotland.

Type
Journal article
Publication
Gut (BMJ)
HCV DAA Cirrhosis